When travellers return with severe infections, the most powerful lessons often emerge after the disease has occurred. This session explores how reverse engineering post-infectious sequelae can reveal critical gaps in pre-travel preparation. Through real-world cases—Hepatitis A (Mexico), Typhoid fever (Pakistan), Yellow Fever (Brazil), and invasive meningococcal disease (Africa)—travel health pharmacist expert Ajit Johal traces illness outcomes back to the original consultation. Pharmacists will gain practical strategies to strengthen risk assessment, vaccine recommendations, and counselling for travellers heading to high-risk destinations.'

By the end of this session, participants will be able to:

1. Identify at least four key exposure risks and destination-specific factors associated with Hepatitis A, Typhoid fever, Yellow Fever, and invasive meningococcal disease in travellers visiting Mexico, Pakistan, Brazil, and sub-Saharan Africa.

2. Apply current travel vaccine recommendations to develop appropriate prevention plans for at least three traveller scenarios, including indications for Hepatitis A, Typhoid, Yellow Fever, and meningococcal vaccination.

3. Analyze post-travel illness cases to identify at least two missed prevention opportunities related to vaccination, food and water precautions, or risk communication during the pre-travel consultation.

4. Integrate a structured risk assessment approach into pharmacy-based travel consultations to improve traveller acceptance of recommended vaccines and preventive strategies for high-risk destinations.

Sponsored by Sanofi